Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines
B Long, R Bridwell, M Gottlieb - The American journal of emergency …, 2021 - Elsevier
Background Current vaccines for the Coronavirus Disease of 2019 (COVID-19) have
demonstrated efficacy with low risk of adverse events. However, recent reports of thrombosis
with thrombocytopenia syndrome (TTS) associated with adenovirus vector vaccines have
raised concern. Objective This narrative review summarizes the current background,
evaluation, and management of TTS for emergency clinicians. Discussion TTS, also known
as vaccine-induced immune thrombotic thrombocytopenia, is a reaction associated with …
demonstrated efficacy with low risk of adverse events. However, recent reports of thrombosis
with thrombocytopenia syndrome (TTS) associated with adenovirus vector vaccines have
raised concern. Objective This narrative review summarizes the current background,
evaluation, and management of TTS for emergency clinicians. Discussion TTS, also known
as vaccine-induced immune thrombotic thrombocytopenia, is a reaction associated with …